# Shandong Boyuan Pharmaceutical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shandong-boyuan-pharmaceutical-co

- Industry: Pharmaceuticals
- Headquarters: Jinan, China
- Website: www.boyuanpharm.com
- Total disclosed funding: $23M
- Latest round: Series A (Apr 21, 2021)
- Investors on record: 2

## About

Established in 2005 and based in Jinan, China, Shandong Boyuan Pharmaceutical Co., Ltd. is a high-tech enterprises specializing in scientific research, production and sales of the professional production of pharmaceutical intermediates and pharmaceutical raw materials of high-tech enterprises. 

The company’s plant is located in Jibei Economic Development Zone. It had built a number of GMP standard-compliant API workshops and synthesis workshops, completes public facilities and auxiliary facilities, establishes a strict quality management system and quality standards in line with international standards, and has advanced quality control methods.

Since establishment, Boyuan Pharma focuses on technological innovation capacity, research and development of new products closely follow the international development of new drugs, and has gradually formed anti-tumor, anti-fungal, analgesics of anesthetics drugs, and hypoglycemic APIs and their pharmaceutical intermediates. The company now owns a number of invention patents with independent intellectual property rights.

## Funding rounds

- Series A, Apr 21, 2021, $23M — Caleb Capital, Addor Capital

## Investors

- Caleb Capital — Series A
- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A